Fundraising Fox
Mission-Driven Tech
Techstars '23Flanders, US · Founded 2022 · 5 employees on LinkedIn · 1 known investors
Find your way into Mission-Driven Tech
Sign up to see every warm intro you have to Mission-Driven Tech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mission-Driven Tech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mission Driven Tech develops medical devices and educational content focused on cervical and uterine cancer treatment. The company offers brachytherapy devices for gynecological cancers and outcome research resources for healthcare professionals.
Also known as MDT
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Mission-Driven Tech (MDT) is a women's health venture focused on cervical cancer, describing itself as a cervical cancer innovation company. Its principal development effort is a modern brachytherapy medical device intended for cervix and uterine cancers, which the company states is still in development. The stated aim of this first initiative is to modernize treatment tools, improve procedure safety and expand access to care by addressing the patient experience and limitations faced by treating physicians.
Alongside the device program, MDT offers two products already on the market: BrachyStories, a CME-accredited outcome improvement research offering aimed at clinicians, and Happy Cervix, a retail line. The Happy Cervix shop sells items such as a 4x6 sticky note pad ("Know Your Risk"), a coaster and a pin, priced between $25 and $50, with the company stating that every $25 purchase funds six minutes of research and development. The venture is described as operating in collaboration with Weill Cornell Medicine and as being in the hospitals and health care sector.
Founding story
The venture is led by Dr. Onyinye Balogun and Eve McDavid, whose backgrounds span healthcare and technology, and was formed in collaboration with Weill Cornell Medicine to address cervical cancer treatment for both patients and physicians.
Business model
MDT combines a pre-commercial medical device program with revenue-generating adjacent offerings: a CME-accredited clinical research and education product (BrachyStories) and a consumer retail line (Happy Cervix). Retail sales are positioned as a contribution to research and development funding, with the company stating that each $25 of purchases funds six minutes of R&D.
Traction
Two products are commercially available — BrachyStories, a CME-accredited outcome improvement research offering, and the Happy Cervix retail line, which includes items listed at $25 to $50, one of which is shown as sold out. The brachytherapy device is described as still in development.
Latest developments
The company states that its modern brachytherapy device for cervix and uterine cancers is forthcoming while its BrachyStories and Happy Cervix products are available.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Positioned as a women's health venture in cervical cancer treatment, developed in collaboration with Weill Cornell Medicine and operating in the hospitals and health care industry.
Technology
The core technology under development is a brachytherapy medical device for cervical and uterine cancers, positioned as a modernization of existing treatment tools with emphasis on procedure safety, access to care, patient experience and physician workflow limitations.
Go-to-market
The company sells Happy Cervix retail products directly through an online shop on its website and distributes CME-accredited outcome improvement research under the BrachyStories brand, while its brachytherapy device remains in development.
Clinicians treating gynecologic cancers, including physicians performing brachytherapy who are the audience for the CME-accredited BrachyStories research offering, as well as consumers purchasing Happy Cervix retail products.
Geography
A third-party profile places the company's headquarters in New York, New York, United States.
History
The company was founded in 2022. A third-party profile lists its headquarters in New York, United States, a team of six employees, and a most recent recorded investment in January 2023.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsA third-party company profile records a January 2023 early-stage investment, listing Pierre N Rolin, founder of Ankh Impact Ventures Limited, as the sole investor on record.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- Mission-Driven Techmissiondriventech.com · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Mission-Driven Tech do?
- Cervical cancer innovation company developing a brachytherapy device for cervix and uterine cancers.
- Who are Mission-Driven Tech's investors?
- Mission-Driven Tech's investors include Techstars.
- Where is Mission-Driven Tech headquartered?
- Mission-Driven Tech is headquartered in Flanders, US.